Heart News and Research

RSS

Masked high blood pressure linked to higher risk of falls in older adults

Masked high blood pressure in adults older than age 78 is associated with a 70% higher risk of falls compared to high blood pressure readings in the office and at home among peers, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

9 Oct 2026

Late-night snacking may affect liver health

New research led by Oregon Health & Science University suggests you should think twice about indulging in a late-night snack if you'd like to preserve liver health.

9 Oct 2026

Real time molecular movie unlocks secrets of penicillin biosynthesis

Researchers from the University of Oxford and international collaborators have revealed previously unseen rapid chemical stages in the formation of β-lactam antibiotics like penicillin, offering insights that can support future antibiotic development.

9 Oct 2026

Study explains why cancer immunity declines faster in males

Lutz Menzel, PhD, formerly of the Department of Radiation Oncology within the Mass General Brigham Cancer Institute, and Tim Padera, PhD, currently of the Mass General Brigham Cancer Institute, are the lead and senior authors of a paper published in Nature Aging, "Lymph node contraction links sex-biased naive CD8 T cell decline to compromised antigen recognition during middle age."

9 Oct 2026

New iron deficiency guidelines raise key blood test cutoffs

ASH 2026 guidelines redefine iron deficiency diagnosis with higher ferritin thresholds, aiming for better detection and management across diverse populations.

9 Oct 2026

AI-powered home monitoring tracks older adults’ health while protecting privacy

Older people could be monitored safely in their own homes without the need for intrusive cameras or wearable devices thanks to new research by Nottingham Trent University (NTU).

8 Oct 2026

Potassium-rich DASH diet does not cause hyperkalemia in individuals taking blood pressure drugs

Increased consumption of potassium-rich foods that are part of the Dietary Approaches to Stop Hypertension (DASH) diet did not raise blood potassium to dangerous levels in people taking medications to lower their blood pressure, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026.

8 Oct 2026

Study explains how sickle cell variant shapes malaria parasite infections

Malaria is one of the deadliest infectious diseases on the planet, afflicting people for the entirety of recorded history.

8 Oct 2026

Skipping water during exercise may limit your body's response to whey protein

Hydration status may influence post-exercise amino acid availability, although effects on muscle recovery remain uncertain.

8 Oct 2026

REUP technique expands access to pediatric heart transplants

A groundbreaking donor heart recovery technique developed at Vanderbilt Health has been successfully adapted for children by pediatric heart transplant surgeons at Monroe Carell Jr. Children's Hospital at Vanderbilt, potentially expanding access to lifesaving heart transplants for children.

7 Oct 2026

Flexible mesh could power implantable electronics without batteries

A team of engineers led by the University of Massachusetts Amherst has designed an ultrathin, flexible mesh that seamlessly integrates electronics with human cells to provide a continuous, reliable, powerful electrical supply.

7 Oct 2026

County analysis reveals deep geographic and racial heart disease disparities

Despite sustained declines in overall cardiovascular disease mortality in the U.S., disparities based on race, ethnicity and place still persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC, the flagship journal of the American College of Cardiology (ACC).

7 Oct 2026

Childhood poverty increases risk of atherosclerosis in adulthood

People who grew up in low-income families are at greater risk of developing atherosclerosis in the coronary arteries later in life.

7 Oct 2026

Study links pregnancy complications to future heart and kidney disease

Women with a complication in the latest pregnancy, or in a previous pregnancy, face an elevated risk of developing cardiometabolic-renal conditions in subsequent years, suggests a UK study published online in the open access journal BMJ Medicine.

6 Oct 2026

Blood protein patterns may help explain pain levels in sickle cell disease

A small pilot study led by a Rutgers researcher has found differences in blood proteins between people experiencing high and low levels of pain from sickle cell disease, findings that may inform research on new treatments and better pain management.

6 Oct 2026

UCLA scientist develops new way to map cellular metabolism

Nutrition advice is everywhere. Eat more protein. Cut back on sugar. Get more fiber. But beneath all that advice is a surprisingly basic gap in our understanding: Scientists still have a limited view of what happens when specific nutrients reach individual cells inside the body.

6 Oct 2026

New AI model detects heart transplant rejection without biopsies

By analyzing heart rhythm recordings and blood tests, artificial intelligence may accurately flag when a transplant patient's body starts attacking a donated heart, a new study suggests.

6 Oct 2026

New global definition changes how childhood obesity is identified

A new global definition of clinical obesity classifies far fewer children as obese than the widely used body mass index (BMI), according to a large international study. And the findings could lead to changes to how childhood obesity is identified and managed.

6 Oct 2026

Study uncovers link between inherited blindness and a gene causing rare metabolic disease

Researchers at the Greenwood Genetic Center (GGC) led the discovery of an unexpected connection between inherited blindness and a gene known for causing a rare metabolic disorder.

6 Oct 2026

SGLT2 inhibitors reduce inflammatory cells linked to heart disease

For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight loss and glucose lowering benefits, has been shown to also reduce inflammatory cells in the blood known to cause cardiovascular disease.

6 Oct 2026